COMPARATIVE-EVALUATION OF THE E-TEST FOR SUSCEPTIBILITY TESTING OF NOCARDIA SPECIES

被引:39
作者
BIEHLE, JR [1 ]
CAVALIERI, SJ [1 ]
SAUBOLLE, MA [1 ]
GETSINGER, LJ [1 ]
机构
[1] GOOD SAMARITAN REG MED CTR, CLIN MICROBIOL SECT, PHOENIX, AZ USA
关键词
D O I
10.1016/0732-8893(94)90120-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The E Test (PDM Epsilometer; AB Biodisk, Solna, Sweden) was compared with microbroth dilution and disk diffusion for antimicrobial susceptibility testing of Nocardia as a collaborative study by two geographically separate laboratories. A total of 52 Clinical isolates and five species of Nocardia were used in this comparative evaluation. Susceptibility testing was performed with Mueller-Hinton media and eight antimicrobial agents. Growth of the test strains with Mueller-Hinton medium was generally satisfactory, with the majority of isolates producing adequate growth within 24-36 h. Growth inhibition ellipses were generally well delineated and uniform for most drugs, and the points of intersection with the E Test strip were generally easy to determine. An inoculum size of similar to 2.0 x 10(7) CFU/ml was optimal for performance of the E Test method with the Nocardiae. Comparison of E rest and microbroth dilution MICs revealed 89.4% agreement for all drugs within +/-1 log(2) dilution. Using NCCLS interpretive criteria for susceptible and resistant results, complete agreement between E Test and disk diffusion results was 93.3%, and between E Test and microbroth dilution results was 96.2%. Interpretive category errors occurred at rates of 18.2% (risk corrected), 0, and 4.1% for very major, major, and minor errors, respectively, when E Test results were compared with disk diffusion results, and 0, 0, and 3.8%, respectively, when E Test was compared with microbroth dilution. Inter- and intra-laboratory reproducibility, within +/-1 log, dilution Jar all drugs, was 95% and 98%, respectively. Results from this study suggest that E Test may be suited for use as an alternative method for antimicrobial susceptibility testing of Nocardia species.
引用
收藏
页码:101 / 110
页数:10
相关论文
共 17 条
[11]   TRIMETHOPRIM-SULFAMETHOXAZOLE THERAPY FOR NOCARDIA INFECTIONS [J].
SMEGO, RA ;
MOELLER, MB ;
GALLIS, HA .
ARCHIVES OF INTERNAL MEDICINE, 1983, 143 (04) :711-718
[12]  
SMEGO RA, 1984, REV INFECT DIS, V6, P164
[13]   DISK DIFFUSION SUSCEPTIBILITY TESTING OF NOCARDIA SPECIES [J].
WALLACE, RJ ;
SEPTIMUS, EJ ;
MUSHER, DM ;
MARTIN, RR .
JOURNAL OF INFECTIOUS DISEASES, 1977, 135 (04) :568-576
[14]  
WALLACE RJ, 1982, REV INFECT DIS, V4, P315
[15]   SUSCEPTIBILITY TESTING OF NOCARDIA SPECIES FOR THE CLINICAL LABORATORY [J].
WALLACE, RJ ;
STEELE, LC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1988, 9 (03) :155-166
[16]   CEFOTAXIME-RESISTANT NOCARDIA-ASTEROIDES STRAINS ARE ISOLATES OF THE CONTROVERSIAL SPECIES NOCARDIA-FARCINICA [J].
WALLACE, RJ ;
TSUKAMURA, M ;
BROWN, BA ;
BROWN, J ;
STEINGRUBE, VA ;
ZHANG, Y ;
NASH, DR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) :2726-2732
[17]  
1992, M2A4 NAT COMM CLIN L